Prevalence of Suicidal Risk in Psychiatric Settings

Completed

Conditions studied: Psychiatric Disorder, Suicidal Crisis

In brief

France is among the countries with one of the highest suicide rates in the world, far ahead of its neighboring nations \[Wasserman et al., 2012\]. Suicide represents the second leading cause of death among 15-24-year-olds, just after road accidents, and the leading cause of death among 25-34-year-olds. In this context, a better utilization of all components of the healthcare system seems highly desirable, particularly through greater involvement of community psychiatrists in suicide prevention strategies. Approximately 25% of individuals who die by suicide have consulted a psychiatrist in the month preceding their death \[Luoma et al., 2002\], yet few data are available on this topic, especially regarding consultations with community psychiatrists outside of hospital settings. Study objectives Main objective To assess the prevalence of suicidal risk during the 15 days preceding an outpatient psychiatric consultation in the Clermont-Ferrand area. Main secondary objectives * To describe the recruited population and potentially associated factors (age, sex, etc.). * To assess the psychological pain of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst. * To assess the self-esteem of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst.

Key facts

Study ID

NCT07746193

Run by

University Hospital, Clermont-Ferrand

People needed

262

Starts

2025-05-01

Expected to finish

2025-06-30

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any adult patient consulting at the psychiatrist's office during the recruitment period (regardless of the reason for consultation) and who has provided consent to participate in this study.

You may not qualify if…

• Minor patient or refusal to participate in the study.
• Patient who has already completed the self-questionnaires previously (e.g., second consultation within the same week).
• Patient unable to understand or complete the self-questionnaires (due to cognitive impairment or insufficient understanding of the French language).

Where it is running

• CHU — Clermont-Ferrand, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.